Abstract
Rupture of the cap of an atherosclerotic plaque can lead to thrombotic cardiovascular events. It has been suggested, through computational models, that the presence of microcalcifications in the atherosclerotic cap can increase the risk of cap rupture. However, the experimental confirmation of this hypothesis is still lacking. In this study, we have developed a novel tissue-engineered model to mimic the atherosclerotic fibrous cap with microcalcifications and assess the impact of microcalcifications on cap mechanics. First, human carotid plaque caps were analyzed to determine the distribution, size, and density of microcalcifications in real cap tissue. Hydroxyapatite particles with features similar to real cap microcalcifications were used as microcalcification mimics. Injected clusters of hydroxyapatite particles were embedded in a fibrin gel seeded with human myofibroblasts which deposited a native-like collagenous matrix around the particles, during the 21-day culture period. Second harmonic multiphoton microscopy imaging revealed higher local collagen fiber dispersion in regions of hydroxyapatite clusters. Tissue-engineered caps with hydroxyapatite particles demonstrated lower stiffness and ultimate tensile stress than the control group samples under uniaxial tensile loading, suggesting increased rupture risk in atherosclerotic plaques with microcalcifications. This model supports previous computational findings regarding a detrimental role for microcalcifications in cap rupture risk and can further be deployed to elucidate tissue mechanics in pathologies with calcifying soft tissues.
INTRODUCTION
Rupture of the cap of an atherosclerotic plaque can lead to cardiovascular events such as myocardial infarction and stroke.1–3 Cap rupture is a material failure of the tissue, which can be analyzed and predicted via stress and strain measurements. Where fibrous cap thickness was thought to be the main determinant of plaque rupture, it is now also acknowledged that the tissue composition of the cap plays a critical role.4,5 The atherosclerotic cap is often characterized by a heterogeneous composition and can contain inflammatory cells, apoptotic cells, and microcalcifications embedded in a collagenous matrix.1,4–6 According to the current definition, microcalcifications are calcified particles, no larger than 50 μm,1 with the main component being hydroxyapatite (HA).7–10 Multiple mechanisms for their formation have been proposed. These include the release of extracellular vesicles,9,11 osteochondrogenic differentiation of smooth muscle cells,12–14 apoptosis,15,16 and a combination of these mechanisms. Microcalcifications are found to be highly prevalent throughout atherosclerotic plaques,17 both in the necrotic core, where they can be seen as floating debris, and in the overlying cap, the latter being possibly critical for cap rupture. Computational studies have suggested an impact of microcalcifications in the cap on mechanical stresses and concomitant rupture risk of the cap.17–23 Microcalcifications were shown to increase the stresses in the fibrous matrix of the cap up to twofold17,18,24 and to shift the maximum stress away from the shoulders of the cap to the location of the microcalcifications,23 suggesting a detrimental role for microcalcifications on cap mechanics and rupture. These models, however, still require experimental validation, especially, because the models assumed isotropic and homogenous mechanical behavior for the cap tissue, which is structurally heterogenous with local dominant collagen fiber orientations.19,25,26 Both calcification characteristics as well as collagen content contribute to plaque instability.17 Furthermore, processes of calcification formation and collagen organization are intertwined,11 showing the importance of assessing the role and interplay of both components in cap mechanics. Therefore, systematic experimental studies are needed to assess the role of microcalcifications in a collagenous matrix, to provide further insight into their effect on plaque cap mechanics.
Unfortunately, ex vivo material of already ruptured plaques is complex due to destroyed morphology while unruptured plaques are possibly not fully representable of the rupturing plaque. Furthermore, human ex vivo material has a heterogeneous composition, complicating elucidating the role of individual cap components. Alternatively, animal models are frequently used, but these are limited due to not being able to adequately mimic the human plaque mechanics. Therefore, to unravel the contribution of microcalcifications on cap mechanics, in vitro models are required, with variable but controllable composition, and suitable for imaging and mechanical testing. Previously we developed a tissue-engineered (TE) human fibrous cap model, where we created reproducible collagenous tissues that mimic the mechanical properties of these caps.27 Capitalizing on our previous studies, here we create a novel cap model with microcalcifications, mimicking analyzed human carotid plaque cap samples. We examined the effect of microcalcification inclusion on cap mechanics and found direct proof that microcalcifications lowered the ultimate tissue stress, indicating a role of microcalcifications in cap vulnerability and mechanics.
RESULTS
Microcalcification size and distribution in human carotid plaque caps
In order to accurately model human microcalcifications, we analyzed microcalcification distribution, size, and abundance in human atherosclerotic carotid plaques [Fig. 1(a)]. Ninety tissue sections were histologically analyzed, of which 44 contained cap tissue. Microcalcifications were observed to be present in plaque cap, both in the shoulder and mid-cap regions as well as in the necrotic core and close to the media layer. In 23 sections, microcalcifications were observed in the atherosclerotic cap and analyzed, with the total microcalcification content (area fraction) within the entire cap being 5% ± 4%. Microcalcifications were distributed nonuniformly throughout the cap and in clusters [Fig. 1(a), zoom]. The clusters were of an ellipsoidal shape in the circumferential direction. In total, 1472 individual microcalcifications were identified within these clusters. Their size ranged between 2 and 52 μm [Fig. 1(b)], with the majority (84% of all particles) being smaller than 15 μm and only a subset (3%) being larger than 30 μm. Microcalcification particle size varied between patients (mean from 3.8 ± 3.1 μm for the cluster with smallest mean particles to 10.6 ± 6.8 μm for biggest), shown in representative images and histograms (supplementary material Fig. 1).The region of interest was established (i.e., the area of the cluster), after which the percentage of the area taken up by microcalcification particles within this cluster was calculated (14% ± 11%).
FIG. 1.
Comparison of microcalcifications in the human atherosclerotic cap to HA particles in the TE-cap. (a) A representative image of an atherosclerotic cap sample, stained with alizarin red for calcification. The zoom-in shows a cluster of microcalcifications. (b) Microcalcification size distribution of human CEA samples. (c) Graphical representation of the TE-cap with a zoom-in showing an alizarin red stained section, showing HA particles. (d) HA particle size distribution in our TE-cap. Scale bars: (a) 1 mm and 100 μm, (c) 100 μm.
HA particles within TE-cap mimic microcalcifications in human cap
HA particles (n = 780) were analyzed and ranged between 1 and 55 μm, with 82% being between 0 and 15 μm [Figs. 1(c) and 1(d)]. Particle size between human microcalcifications and purchased HA particles were similar (p = 0.93). No abundant cell death was observed of HVSCs after the addition of HA particles compared to control (supplementary material Fig. 2), and MTT data showed no significant differences with and without HA particles (supplementary material Fig. 3). Based on the microcalcification characteristics of human cap data [Fig. 1(a)], TE-caps were created with clustered HA particles [Fig. 1(c)]. Multiple clusters were created (on average 5 per sample) and within each cluster, HA particles comprised 11% ± 6% of the area of the cluster, as analyzed with bright-field microscopy, comparable to human cap clusters of CEA specimens (p = 0.32). Cluster size and particle density were further visually compared in Alizarin Red S stained sections and showed similar size and particle distribution [Figs. 1(a) and 1(c), zoom]. Additionally, both clusters in human samples as well as in the TE-cap showed an ellipsoidal morphology, visually orienting along the fiber directionality [Figs. 1(a) and 1(c), zoom].
FIG. 2.
Global tissue comparison of the TE-cap models with and without clusters of microcalcifications. (a) Representative photographs showing samples at day 5 and day 21 of culture, with and without microcalcifications. (b) Compaction of two groups showing similar compaction over the culture period. (c) Tile-scan of bright-field microscopy images of a sample with HA clusters, clearly visible with this imaging method, and a control sample. (d) Cell number (DNA) and collagen (HYP) levels normalized to the total tissue mass. (e) Representative PSR staining of collagen (red/pink) with zoom-in showing HA particles located between the fibers. (f) Representative Von Kossa staining of adjacent section for HA particles (black) with Nuclear Fast Red counterstain (pink). Scale bars: (e) and (f) 200 μm and zoom-in 50 μm, arrow indicates same microcalcification.
FIG. 3.
Collagen organization and microcalcification clusters at day 21. (a) Representative HA cluster visualized (red) in combination with collagen fibers (blue/green). 2 z-stacks stitched together. (b) Control area of collagen, showing collagen alignment. (c) 3D reconstruction of z-stack showing collagen matrix surrounding the HA particles. (d) κ values, a dispersion parameter, show a significantly higher dispersion for areas with HA clusters compared to control areas. Scale bars (a)–(c) 100 μm.
Composition and geometry of TE-caps
At the end of the 21-day tissue culturing period, all TE-caps showed compaction in the lateral direction [Fig. 2(a)]. No significant difference was detected between the TE-caps with and without HA [Fig. 2(b)]. Visual inspection of the bright-field images [Fig. 2(c)] demonstrated ellipsoidal shapes of HA clusters, with the major axis in the direction of the stretch applied during tissue culturing due to the Velcro constraints. They had a mean area of 0.8 ± 0.6 mm2 per cluster. DNA content normalized to tissue dry weight showed no differences in the amount of cells between TE-caps with and without HA [Fig. 2(d)]. Furthermore, no differences between the groups were observed in collagen produced per DNA [Fig. 2(d)].
PSR and Von Kossa stainings of adjacent sections of the TE-cap [Figs. 2(e) and 2(f)] demonstrated that the collagen fibers were aligned predominantly in the direction of the constraints and surrounded the HA particles, causing the particles to be embedded in the matrix. Visually, no differences were observed in deposited collagen matrix and cellular presence, visualized by Nuclear Fast Red staining, in proximity to the HA clusters compared to elsewhere in the same sample [Figs. 2(e) and 2(f)]. Cellular proximity to HA particles was further analyzed to rule out the effect of cellular aggregation around HA particles on local collagen deposition. No significant differences in cell number in regions with HA particles and without were found (supplementary material Fig. 4). Furthermore, HA morphology could be observed in the Von Kossa staining, revealing that the bigger HA particles (i.e., between 10 and 50 μm) consisted of agglomerated microparticles [Fig. 2(f), arrow].
FIG. 4.
Global mechanical characterization of tissues. (a) Normalized ultimate stress showing a significant decrease for the samples with HA particles. (b) Normalized ultimate strain showing no differences between groups. (c) Normalized stiffness value at 10% strain, showing a significant decrease for groups with HA particles. (d) Correlation between the dispersion values kappa, obtained from SHG imaging and the normalized stiffness values, displaying a negative correlation.
Effect of the presence of HA on local collagen organization
Z-stacks were obtained of 43 control areas (areas measured in samples without HA clusters) and 36 areas with HA clusters. SHG microscopy images demonstrated that HA particles were embedded in the collagen matrix, with collagen fibers bordering the particles [Fig. 3(a)]. Collagen fibers aligned in the direction of the Velcro constraints (y-direction) in control areas [Fig. 3(b)]. The 3D rendering of a cluster showed collagen fibers closely surrounding the particles [Fig. 3(c)]. For control areas the median dispersion (κ) was calculated to be 0.14 (0.01, 0.19), while for areas with HA clusters, this was 0.19 (0.12, 0.21) (p = 0.0022) (Fig. 3(d)], indicating more dispersed collagen orientation in the areas with HA clusters.
Effect of HA on TE-caps' mechanical behavior
The ultimate tensile stress (UTS), i.e., maximum stress measured, was found to be significantly lower for samples with HA clusters (p = 0.0096) [Fig. 4(a)]. No differences were found in strain corresponding to UTS (ultimate strain) between experimental groups [Fig. 4(b)]. Samples with HA clusters were found to be significantly less stiff in the tensile direction at 10% strain (p = 0.011) [Fig. 4(c)]. These global stiffness values were correlated with the local dispersion coefficient κ, obtained from SHG imaging. A negative correlation was found between sample stiffness and collagen κ values (R2 = 0.691) [Fig. 4(d)].
DISCUSSION
Within this study, we have created an in vitro TE model of the human atherosclerotic cap with its collagenous matrix and microcalcifications. This model can serve as an in vitro platform to further elucidate the role of microcalcifications on local and global atherosclerotic cap mechanics and rupture. In addition, local collagen interactions with microcalcifications can be studied, making it suitable for studying both atherosclerosis and other pathological calcification conditions. To mimic human plaque cap microcalcifications, commercially available HA particles were compared to microcalcifications of human CEA samples, after which they were incorporated in a TE human fibrous cap model. SHG confocal imaging and histological analysis were performed to assess local collagen organization in proximity to HA particles, showing that HA particles influenced the dispersion of collagen fibers. Uniaxial tensile testing unraveled the global mechanical effect of the clusters, with lowered UTS and stiffness in samples with HA clusters, revealing a role for microcalcifications on cap mechanics.
Human carotid plaque samples were analyzed for microcalcification size and density in the cap region as input to our TE model. Microcalcifications were observed in clusters, consistent with μCT analysis of microcalcifications in human coronary plaques.17 Particle size analysis showed that the majority of the microcalcifications of human CEA plaques had a diameter between 2 and 15 μm, while only a small subset (16%) was larger in size. This was also in line with previous μCT analysis, where 80% was found to be between 5 and 15 μm.17 In this study, we chose to incorporate clustering and inhomogeneous distribution in the TE model, matching with our human carotid plaque findings.
For the creation of this model, we made use of HVSCs to deposit the collagenous matrix of the TE-samples. The choice for HVSCs, a type of myofibroblast, was made because of their established role, obtained from previous experience,27–29 in collagen deposition and remodeling.30 Since adventitial myofibroblasts are furthermore thought to play a role in fibrous cap formation,31 the HVSCs were chosen as a suitable cell source for answering the mechanically relevant questions of this research. The fiber alignment of the collagenous matrix deposited by the HVSCs was assessed using SHG confocal imaging. In general, collagen fibers aligned along the direction of the constraints. This correlated well with the in vivo situation, as it was found that collagen fibers mainly align along the circumferential direction.32 In our TE human fibrous cap model with HA particles, the particles became embedded in the collagen matrix formed by HVSCs, as was observed both by confocal imaging and histology. Hutcheson et al. described that collagen can facilitate microcalcification aggregation and growth, leading to microcalcifications being formed between collagen fibers.11,33 Although collagen fibers formed after the addition of the HA particles in our model, the end result compared well to Hutcheson's findings and the human carotid plaque caps we analyzed histologically, with microcalcifications located in between the collagen fibers.
Our model serves as a tunable platform in which the interplay between the collagenous matrix and HA particles can be studied, and their role on tissue mechanics can be analyzed. Using our model, we detected that the incorporation of HA particles lowered the UTS, which was also observed in a recent experimental study by the group of Cardoso,34 where micro-beads were incorporated in a silicone-based model. The reduction in UTS could possibly be explained by a local stress increase at the tensile poles, as described in multiple computational models, which show that microcalcifications can be seen as local stress concentrators,17,19,35,36 an effect that could be present in our model and was also hypothesized by Cardoso.34 However, future research should focus on rupture path analysis to confirm the hypothesis that microcalcifications directly affect cap mechanics and rupture. Another factor to take into consideration with regard to tissue mechanics is the collagenous matrix, since this is the main load-bearing component of the fibrous cap.32,37 In our model, it was shown that HA particles influence the dispersion of collagen fibers and since collagen isotropy was shown to lower rupture stresses,38 the HA-induced effect on collagen matrix dispersion could play a role in the lowered UTS. Currently, it is yet unknown if either the dispersity of the collagen fibers or the local inhomogeneity caused by the microcalcifications is the causative mechanism of lower tissue strength. Additionally, samples with HA clusters had a lower global stiffness when compared to samples without these clusters. This may be counterintuitive, since literature on calcified plaque tissue often shows higher stiffness compared to non-calcified tissue,1 but these are data on macrocalcifications instead of microcalcifications. The lower stiffness of samples with microcalcifications could be attributed to the local higher collagen dispersion, as dispersed fiber orientations were found to reduce tissue stiffness when compared to highly aligned fibers,39,40 further highlighting not only the effect of HA inclusions but their effect on collagen architecture, thus indirectly affecting cap mechanics.
With our model, we were able to assess the effect of clustered HA particles on collagen organization and tissue strength and stiffness. However, in computational models, it has been discovered that there are various characteristics of microcalcifications that can influence the local stress accumulations they cause. It was found that they have the most consequential effect depending on their size,34,41 location,24 shape,17,36 and spacing.35 With regard to size, it has been shown that microcalcifications smaller than 5 μm should not be biomechanically dangerous.41 Second, the location of the particles is of importance, as microcalcifications located in a thin cap compromise the mechanical stability of the cap the most.24 Furthermore, it has been shown that ellipsoidal particles could be even more harmful than spherical microcalcifications.17,36 Finally, local stress levels can increase up to a factor five if the microcalcifications are closely spaced and aligned along the tensile axis.35 Since these are all computational findings, future use of our model could experimentally validate or dismiss these findings by adjusting the concentration, size range, and shape of the particles used.
CONCLUSION
In conclusion, we have created a TE fibrous cap model with a mimic of microcalcifications to study the effect of microcalcifications on atherosclerotic cap mechanics, and found a relation between microcalcification inclusions and lowered UTS and stiffness. Since cap mechanics change due to the iterative interplay between cap components and environmental cues,29,42,43 plaque rupture is stochastic. Many of the underlying mechanisms are still unknown, while understanding these could enhance risk assessment by identifying new imaging biomarkers and therapeutic agents. This model can serve as an in vitro cell-based model to further understand local interactions between collagen fibers and calcification, with regard to tissue mechanics and rupture.
METHODS
Characterization of microcalcifications in human carotid plaque caps
Human carotid plaque samples were obtained from seven patients that underwent carotid endarterectomy (CEA) in the Erasmus University Medical Center Rotterdam, the Netherlands. Samples were acquired in a manner that fulfilled the declaration of Helsinki and was approved by the hospital's Ethical Research Committee (MEC 2008–147). Histological cross sections of 5 μm thickness (n = 90) were obtained and classified into three groups according to the American Heart Association (AHA) plaque classification. Segments with pathological intimal thickening (PIT, n = 15, 17%) showed areas of inflammatory infiltration without necrotic tissue. The fibrous cap atheroma (FCA, n = 38, 42%) consisted morphologically of a necrotic core and overlying fibrous cap with inflammatory cells. The fibrocalcific segments (FCALC, n = 37, 41%) contained heavy areas of calcification within the necrotic core. Microcalcification localization, clustering, density, and size were analyzed by Alizarin Red S staining, using FIJI Image J software (US National Institutes of Health, Bethesda, MD, USA). Particle size was calculated by creating an eight-bit image of the alizarin stained section, after which the image threshold was set, so that only alizarin red stained particles were selected. Particle measurements were performed using the build-in particle analysis tool in ImageJ.
The effect of HA particles on human vena saphena cell (HVSC) viability
As a mechanical equivalent of microcalcifications, HA particles (Plasma Biotal Limited) were used. The effect of HA particles on HVSC viability was assessed by culturing HVSCs in a monolayer in the presence of HA particles. HVSCs were isolated from two donors (63-year-old female and 72-year-old male) after coronary bypass surgery according to previously established protocols30 conform the Dutch advice for secondary-use material. HVSCs were seeded in 12 well plates at a seeding density of 5000 cells/cm2. After 24 h, HA particles (0.05 mg/ml) were added to the culture medium and cultured for an additional 10 days. The medium was changed every 3 days, and at each medium change, bright-field images were taken to assess cell morphology. No new HA particles were added to the culture medium, as these particles attached to the cells and the wells plate and thus stayed in culture the entire period. After 10 days, a MTT (Thiazolyl Blue Tetrazolium Bromide, M5655, Sigma) assay was performed according to the manufacturer's protocols to analyze the metabolic activity of the cells.
Creation of TE plaque caps
TE plaques without HA particles were created following the methodology described previously.27 To summarize, human vena saphena cells (HVSCs) (1.5 × 106 cells/ml) were seeded in 1.0 × 1.5 cm-sized fibrin gels, a suspension of bovine fibrinogen (10 mg/ml, Sigma F8630), and bovine thrombin (10 U/ml, Sigma T4648), cast between two Velcro strips (1 cm long). After seeding, the samples were cultured in a growth medium consisting of advanced DMEM (ThermoFisher) supplemented with 10% Fetal Bovine Serum (Life Technologies), 1% Glutamax (Gibco), 0.1% gentamycin (Invitrogen), 1:167 Fungizone (Invitrogen), and L-ascorbic acid 2-phosphate (vitamin C, 0.25 mg/ml, Sigma A8960) for 21 days under static conditions (37 °C, 5% CO2). For the first 7 days of culture, ε-Amino Caproic Acid (ε-ACA, 1 mg/ml, Sigma) was added to prevent fibrin break-down.28
Incorporation of HA clusters in TE plaque caps
To create tissues with HA clusters, a suspension of bovine fibrinogen and HA microparticles (0.25 mg/ml) was created. Directly after seeding of the suspension fibrinogen, thrombin, and HVSCs between the Velcro strips, clusters of 3 μl HA particle-fibrin suspension were injected with a pipette, just before complete gelation of the HVSC-fibrin gel. The samples were then placed in an incubator to set for 30 min, after which medium was added. Samples were subsequently cultured for 21 days under static conditions.
Imaging of TE plaque caps
Assessment of HA cluster incorporation in TE plaque caps
Bright-field microscopy images (Olympus CKX41, Olympus Life Science) of the areas with HA clusters were taken every 7 days, as well as images of the control samples without clusters. Images were captured by the Olympus SC30 camera, making use of the AnalySIS getIT software (Olympus Soft Imaging Solutions GmbH). Global tissue geometry was assessed and images were used to assess size and localization of HA clusters and particles within these clusters. The mean size of HA particles was characterized using Image J analysis.
Assessment of collagen organization in TE plaque caps with and without HA clusters
After the culturing period, the samples (n = 13 with HA clusters and n = 11 control) were rinsed with Phosphate Buffered Saline (PBS). The samples with HA clusters were incubated with an HA-targeting probe (IVISense Osteo 680 Fluorescent Probe, Osteosense, PerkinElmer), diluted 1:200 in PBS at 4 °C for 48 h. Following incubation, samples were rinsed with PBS and were pinned to a silicone-filled (Sylgard 184, VWR, Germany) Petri-dish with sterile surgical needles. PBS was added to fully submerge the sample. A multiphoton microscope (TCS SP5 Confocal, Leica, Germany) with a Chameleon Ultra multiphoton laser (710–1040 nm) (Coherent, USA) was used to visualize collagen architecture and HA clusters. First, a bright-field tile scan of the sample was made to localize HA clusters. Next, second harmonic generation (SHG) using two-photon microscopy (excitation of 880 nm) was employed to image collagen fibers in combination with confocal microscopy of the HA clusters (excitation of 680 nm). Z-stacks (tile size 739 × 739μm, step size 3 μm, pixel size 1.4 × 1.4 μm) to a depth of approximately 200 μm were collected in areas with and without HA clusters.
For data analysis, the maximum intensity projection (MIP) of each scanned tile was obtained and further analyzed using the Fiblab44 software to extract the orientation of individual collagen fibers. The predominant angle and the dispersion (κ) of the fiber orientations45 were measured per tile to assess the (an)isotropy of the engineered tissues.
Tissue analysis
After SHG imaging, two samples from each group were further processed for histological examination. The samples were rinsed with PBS, fixed in 3.6% formaldehyde for 1 h, and then stored at 4 °C for later histological analysis. The other samples (n = 11 with HA and n = 9 control) were used for mechanical testing until rupture.
Mechanical characterization: Uniaxial tensile testing
Uniaxial tensile tests were performed after SHG imaging to assess the effect of HA clusters on TE caps' mechanical properties. Before testing, samples were rinsed in PBS and imaged with a high frequency, high spatial resolution ultrasound system (VEVO 3100, FUJIFILM VisualSonics, Canada) using a linear transducer (MX550) to assess the dimensions of the central region of the sample. For uniaxial tensile testing, a custom-designed set-up46,47 equipped with a 20 N load cell (LCMFD-20N, Omega Engineering, USA) was used. The samples were placed, in the uniaxial tensile tester using the Velcro constraints, and the tests were performed while the samples were submerged in PBS at 37 °C. A pre-load of 0.05 N was applied to remove tissue slack and 10 cycles of preconditioning up to 10% strain48 were performed before the final uniaxial tensile stretching cycle until complete rupture at a strain rate of 200%/min.
Effective tensile engineering stress–strain behavior of the samples for the final uniaxial tensile stretch cycle was calculated, and ultimate tensile stress and strain, the tangential modulus at 10% strain, were assessed.49,50 Cross-sectional area measurements from the ultrasound scans were used for stress calculations and gauge length for the strain measurements. After mechanical testing, the ruptured samples were stored for determining the cell (DNA) and collagen (hydroxyproline (HYP)) content.
Tissue composition: DNA and collagen content
Samples (n = 11 with HA and n = 9 control) used for DNA and HYP determination were lyophilized, weighed, and digested in a papain digestion buffer (100 mM phosphate buffer (pH = 6.5), 5 mM L-cysteine (C-1276), 5 mM ethylene-di-amine-tetra-acetic acid (EDTA, ED2SS), and 140 μg/ml papain (P4762), all from Sigma-Aldrich. Each sample was mixed with 300 μl of digestion buffer in a new Eppendorf tube and placed at 60 °C for 16 h for digestion. Digested samples were vortexed and centrifuged (12 000 rpm, 10 min), and the DNA content was quantified using the Qubit dsDNA BR kit (Life Technologies, Carlsbad, California, USA) and the Qubit fluorometer (Life Technologies), following the manufacturer's instructions.
To quantify HYP content, digested samples were hydrolyzed using 16M sodium hydroxide. Subsequently, HYP content was quantified using the Chloramin-T assay, including trans-4-hydroxyproline as a reference (Sigma, H5534).48 HYP content was then normalized for DNA content.
Tissue composition: Histology
7 μm thick cryosections, cut in the z-direction, were analyzed to evaluate global collagen matrix structure and HA clusters and to compare HA particle size and cluster density to the human CEA histological analysis. Fibrillar collagen could be visualized with Picrosirius Red (PSR), while HA particles were stained with Von Kossa and Alizarin Red S. For the PSR staining, samples were stained in PSR solution for 60 min, after which they were washed in acetic acid and dehydrated in a series of ethanol. For Alizarin Red S staining, the sections were stained in Alizarin Red S solution (pH = 4.4) for 15 min, rinsed in Milli-Q, and dehydrated in acetone and acetone–xylene (1:1). The Von Kossa staining was performed by staining sections in a silver nitrate solution for 30 min on a bright light. Afterward, they were rinsed in Milli-Q, counterstained with Nuclear Fast Red, and dehydrated. Stained sections were embedded in enthalan and imaged with bright-field microscopy (Olympus BX50).
Statistical analysis
All data are presented as mean ± standard deviation unless stated otherwise. Statistical analyses were performed using Prism (GraphPad, La Jolla, CA, USA). A Shapiro-Wilk test was performed for normality. In the case of proven normality, an unpaired T-test was performed, and a nonparametric Mann-Whitney U test otherwise. Mechanical parameters (stress, strain, and stiffness) values were normalized to the mean of control samples within each separate experiment, to adjust for cell donor variability. Differences were considered statistically significant for p values < 0.05 (visualized as *p < 0.05; **p < 0.01; and ***p < 0.001).
SUPPLEMENTARY MATERIAL
See the supplementary material for representative images of the Alizarin Red S stained carotid endarterectomy samples of the donors, representative bright-field images of the monolayer experiment, MTT assay data, and histological images and quantification of cellular proximity to HA particles.
ACKNOWLEDGMENTS
This work was funded by an NWO-Vidi Grant (No. 18360).
Contributor Information
Imke Jansen, Email: mailto:i.jansen@erasmusmc.nl.
Eric Farrell, Email: mailto:e.farrell@erasmusmc.nl.
Kim van der Heiden, Email: mailto:k.vanderheiden@erasmusmc.nl.
AUTHOR DECLARATIONS
Conflict of Interest
The authors have no conflicts to disclose.
Ethics Approval
Ethics approval for experiments reported in the submitted manuscript on animal or human subjects was granted. CEA samples were acquired in a manner that fulfilled the declaration of Helsinki and was approved by the hospital's Ethical Research Committee (MEC 2008-147).
Author Contributions
Eric Farrell and Kim van der Heiden contributed equally to this work.
Imke Jansen: Conceptualization (equal); Formal analysis (equal); Methodology (equal); Visualization (equal); Writing – original draft (equal). Hanneke Crielaard: Investigation (equal); Writing – review & editing (equal). Tamar Wissing: Methodology (equal); Writing – review & editing (equal). Carlijn Bouten: Writing – review & editing (equal). Frank Gijsen: Conceptualization (equal); Supervision (equal); Writing – review & editing (equal). Ali Akyildiz: Writing – review & editing (equal). Eric Farrell: Conceptualization (equal); Supervision (equal); Writing – review & editing (equal). Kim van der Heiden: Conceptualization (equal); Funding acquisition (equal); Supervision (equal); Writing – review & editing (equal).
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding authors upon reasonable request.
References
- 1. Barrett H. E., Van der Heiden K., Farrell E., Gijsen F. J. H., and Akyildiz A. C., “ Calcifications in atherosclerotic plaques and impact on plaque biomechanics,” J. Biomech. 87, 1–12 (2019). 10.1016/j.jbiomech.2019.03.005 [DOI] [PubMed] [Google Scholar]
- 2. Herrington W., Lacey B., Sherliker P., Armitage J., and Lewington S., “ Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease,” Circ. Res. 118, 535–546 (2016). 10.1161/CIRCRESAHA.115.307611 [DOI] [PubMed] [Google Scholar]
- 3. Libby P. et al. , “ Atherosclerosis,” Nat. Rev. Dis. Primers 5, 56 (2019). 10.1038/s41572-019-0106-z [DOI] [PubMed] [Google Scholar]
- 4. Finn A. V., Nakano M., Narula J., Kolodgie F. D., and Virmani R., “ Concept of vulnerable/unstable plaque,” Arterioscler. Thromb. Vasc. Biol. 30, 1282–1292 (2010). 10.1161/ATVBAHA.108.179739 [DOI] [PubMed] [Google Scholar]
- 5. Virmani R., Burke A. P., Farb A., and Kolodgie F. D., “ Pathology of the vulnerable plaque,” J. Am. Coll. Cardiol. 47, C13–C18 (2006). 10.1016/j.jacc.2005.10.065 [DOI] [PubMed] [Google Scholar]
- 6. Lendon C. L., Davies M. J., Born G. V. R., and Richardson P. D., “ Atherosclerotic plaque caps are locally weakened when macrophages density is increased,” Atherosclerosis 87, 87–90 (1991). 10.1016/0021-9150(91)90235-U [DOI] [PubMed] [Google Scholar]
- 7. New S. E. P. and Aikawa E., “ The role of extracellular vesicles in de novo mineralization: An additional novel mechanism of cardiovascular calcification,” Arterioscler. Thromb. Vasc. Biol. 33, 1753 (2013). 10.1161/ATVBAHA.112.300128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Moss A. J. et al. , “ Ex vivo 18F-fluoride uptake and hydroxyapatite deposition in human coronary atherosclerosis,” Sci. Rep. 10, 1–9 (2020). 10.1038/s41598-020-77391-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Perrotta I. and Perri E., “ Ultrastructural, elemental and mineralogical analysis of vascular calcification in atherosclerosis,” Microsc. Microanal. 23, 1030–1039 (2017). 10.1017/S1431927617012533 [DOI] [PubMed] [Google Scholar]
- 10. Aikawa E. et al. , “ Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo,” Circulation 116, 2841–2850 (2007). 10.1161/CIRCULATIONAHA.107.732867 [DOI] [PubMed] [Google Scholar]
- 11. Hutcheson J. D. et al. , “ Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques,” Nat. Mater. 15, 335–343 (2016). 10.1038/nmat4519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Lin M. E. et al. , “ Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation,” Cardiovasc. Res. 112, 606–616 (2016). 10.1093/cvr/cvw205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Shioi A. et al. , “ Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: Roles of tumor necrosis factor-α and oncostatin M derived from macrophages,” Circ. Res. 91, 9–16 (2002). 10.1161/01.RES.0000026421.61398.F2 [DOI] [PubMed] [Google Scholar]
- 14. Otsuka F., Sakakura K., Yahagi K., Joner M., and Virmani R., “ Has our understanding of calcification in human coronary atherosclerosis progressed?,” Arterioscler. Thromb. Vasc. Biol. 34, 724–736 (2014). 10.1161/ATVBAHA.113.302642 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Mori H. et al. , “ Coronary artery calcification and its progression: What does it really mean?,” JACC Cardiovasc. Imaging 11, 127–142 (2018). 10.1016/j.jcmg.2017.10.012 [DOI] [PubMed] [Google Scholar]
- 16. Jinnouchi H. et al. , “ Diversity of macrophage phenotypes and responses in atherosclerosis,” Cell. Mol. Life Sci. 77, 1919–1932 (2020). 10.1007/s00018-019-03371-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kelly-Arnold A. et al. , “ Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries,” Proc. Natl. Acad. Sci. U. S. A. 110, 10741–10746 (2013). 10.1073/pnas.1308814110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Rambhia S. H. et al. , “ Microcalcifications increase coronary vulnerable plaque rupture potential: A patient-based micro-CT fluid-structure interaction study,” Ann. Biomed. Eng. 40, 1443–1454 (2012). 10.1007/s10439-012-0511-x [DOI] [PubMed] [Google Scholar]
- 19. Maldonado N., Kelly-Arnold A., Laudier D., Weinbaum S., and Cardoso L., “ Imaging and analysis of microcalcifications and lipid/necrotic core calcification in fibrous cap atheroma,” Int. J. Cardiovasc. Imaging 31, 1079 (2015). 10.1007/s10554-015-0650-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bluestein D. et al. , “ Influence of microcalcifications on vulnerable plaque mechanics using FSI modeling,” J. Biomech. 41, 1111–1118 (2008). 10.1016/j.jbiomech.2007.11.029 [DOI] [PubMed] [Google Scholar]
- 21. Cilla M., Monterde D., Pena E., and Martinez M. A., “ Does microcalcification increase the risk of rupture?,” Proc. Inst. Mech. Eng., Part H 227, 588–599 (2013). 10.1177/0954411913479530 [DOI] [PubMed] [Google Scholar]
- 22. Vengrenyuk Y. et al. , “ A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps,” Proc. Natl. Acad. Sci. U. S. A. 103, 14678–14683 (2006). 10.1073/pnas.0606310103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Wenk J. F., Papadopoulos P., and Zohdi T. I., “ Numerical modeling of stress in stenotic arteries with microcalcifications: A micromechanical approximation,” J. Biomech. Eng. 132, 014503 (2010). 10.1115/1.4001351 [DOI] [PubMed] [Google Scholar]
- 24. Corti A. et al. , “ The effect of plaque morphology, material composition and microcalcifications on the risk of cap rupture: A structural analysis of vulnerable atherosclerotic plaques,” Front. Cardiovasc. Med. 9, 2875 (2022). 10.3389/fcvm.2022.1019917 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Douglas G. R. et al. , “ Impact of fiber structure on the material stability and rupture mechanisms of coronary atherosclerotic plaques,” Ann. Biomed. Eng. 45, 1462–1474 (2017). 10.1007/s10439-017-1827-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Stöger J. L. et al. , “ Distribution of macrophage polarization markers in human atherosclerosis,” Atherosclerosis 225, 461–468 (2012). 10.1016/j.atherosclerosis.2012.09.013 [DOI] [PubMed] [Google Scholar]
- 27. Wissing T. B. et al. , “ Tissue-engineered collagenous fibrous cap models to systematically elucidate atherosclerotic plaque rupture,” Sci. Rep. 12, 1–13 (2022). 10.1038/s41598-022-08425-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. De Jonge N., Kanters F. M. W., Baaijens F. P. T., and Bouten C. V. C., “ Strain-induced collagen organization at the micro-level in fibrin-based engineered tissue constructs,” Ann. Biomed. Eng. 41, 763–774 (2013). 10.1007/s10439-012-0704-3 [DOI] [PubMed] [Google Scholar]
- 29. Rubbens M. P. et al. , “ Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue,” Tissue Eng., Part A 15, 999–1008 (2009). 10.1089/ten.tea.2007.0396 [DOI] [PubMed] [Google Scholar]
- 30. Schnell A. M. et al. , “ Optimal cell source for cardiovascular tissue engineering: Venous vs. aortic human myofibroblasts,” Thorac. Cardiovasc. Surg. 49, 221–225 (2001). 10.1055/s-2001-16113 [DOI] [PubMed] [Google Scholar]
- 31. Sartore S. et al. , “ Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant,” Circ. Res. 89, 1111–1121 (2001). 10.1161/hh2401.100844 [DOI] [PubMed] [Google Scholar]
- 32. Akyildiz A. C. et al. , “ 3D Fiber orientation in atherosclerotic carotid plaques,” J. Struct. Biol. 200, 28–35 (2017). 10.1016/j.jsb.2017.08.003 [DOI] [PubMed] [Google Scholar]
- 33. Zhao Y., Sun Z., Li L., Yuan W., and Wang Z., “ Role of collagen in vascular calcification,” J. Cardiovasc. Pharmacol. 80, 769–778 (2022). 10.1097/FJC.0000000000001359 [DOI] [PubMed] [Google Scholar]
- 34. Corti A., Khalil D., De Paolis A., and Cardoso L., “ Size and proximity of micro-scale hard-inclusions increase the risk of rupture in fibroatheroma-like laboratory models,” J. Mech. Behav. Biomed. Mater. 141, 105749 (2023). 10.1016/j.jmbbm.2023.105749 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Maldonado N., Kelly-Arnold A., Cardoso L., and Weinbaum S., “ The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding,” J. Biomech. 46, 396–401 (2013). 10.1016/j.jbiomech.2012.10.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Cardoso L., Kelly-Arnold A., Maldonado N., Laudier D., and Weinbaum S., “ Effect of tissue properties, shape and orientation of microcalcifications on vulnerable cap stability using different hyperelastic constitutive models,” J. Biomech. 47, 870 (2014). 10.1016/j.jbiomech.2014.01.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Holzapfel G. A., Gasser T. C., and Stadler M., “ A structural model for the viscoelastic behavior of arterial walls: Continuum formulation and finite element analysis,” Eur. J. Mech. A/Solids 21, 441–463 (2002). 10.1016/S0997-7538(01)01206-2 [DOI] [Google Scholar]
- 38. Tornifoglio B., Johnston R. D., Stone A. J., Kerskens C., and Lally C., “ Microstructural and mechanical insight into atherosclerotic plaques: An ex vivo DTI study to better assess plaque vulnerability,” Biomech. Model. Mechanobiol. 22, 1515–1530 (2023). 10.1007/s10237-022-01671-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Whelan A. et al. , “ Collagen fibre orientation and dispersion govern ultimate tensile strength, stiffness and the fatigue performance of bovine pericardium,” J. Mech. Behav. Biomed. Mater. 90, 54–60 (2019). 10.1016/j.jmbbm.2018.09.038 [DOI] [PubMed] [Google Scholar]
- 40. Johnston R. D., Gaul R. T., and Lally C., “ An investigation into the critical role of fibre orientation in the ultimate tensile strength and stiffness of human carotid plaque caps,” Acta Biomater. 124, 291–300 (2021). 10.1016/j.actbio.2021.02.008 [DOI] [PubMed] [Google Scholar]
- 41. Maldonado N. et al. , “ A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: Potential implications for plaque rupture,” Am. J. Physiol.-Hear. Circ. Physiol. 303, 619–628 (2012). 10.1152/ajpheart.00036.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Heeneman S. et al. , “ The dynamic extracellular matrix: Intervention strategies during heart failure and atherosclerosis,” J. Pathol. 200, 516–525 (2003). 10.1002/path.1395 [DOI] [PubMed] [Google Scholar]
- 43. Wissing T. B. et al. , “ Hemodynamic loads distinctively impact the secretory profile of biomaterial-activated macrophages—Implications for in situ vascular tissue engineering,” Biomater. Sci. 8, 132–147 (2020). 10.1039/C9BM01005J [DOI] [PubMed] [Google Scholar]
- 44. Van Haaften E. E. et al. , “ Decoupling the effect of shear stress and stretch on tissue growth and remodeling in a vascular graft,” Tissue Eng., Part C 24, 418–429 (2018). 10.1089/ten.tec.2018.0104 [DOI] [PubMed] [Google Scholar]
- 45. Annaidh A. N. et al. , “ Automated estimation of collagen fibre dispersion in the dermis and its contribution to the anisotropic behaviour of skin,” Ann. Biomed. Eng. 40, 1666–1678 (2012). 10.1007/s10439-012-0542-3 [DOI] [PubMed] [Google Scholar]
- 46. Crielaard H. et al. , “ A method to study the correlation between local collagen structure and mechanical properties of atherosclerotic plaque fibrous tissue,” J. Vis. Exp. 2022, e64334. 10.3791/64334 [DOI] [PubMed] [Google Scholar]
- 47. Torun S. G. et al. , “ Local characterization of collagen architecture and mechanical failure properties of fibrous plaque tissue of atherosclerotic human carotid arteries,” Acta Biomater. 164, 293–302 (2023). 10.1016/j.actbio.2023.04.022 [DOI] [PubMed] [Google Scholar]
- 48. Huszar G., Maiocco J., and Naftolin F., “ Monitoring of collagen and collagen fragments in chromatography of protein mixtures,” Anal. Biochem. 105, 424–429 (1980). 10.1016/0003-2697(80)90481-9 [DOI] [PubMed] [Google Scholar]
- 49. Paini A. et al. , “ Multiaxial mechanical characteristics of carotid plaque: Analysis by multiarray echotracking system,” Stroke 38, 117–123 (2007). 10.1161/01.STR.0000251796.38954.b2 [DOI] [PubMed] [Google Scholar]
- 50. Huang J. et al. , “ Radial wall strain assessment from AI-assisted angiography: Feasibility and agreement with OCT as reference standard,” J. Soc. Cardiovasc. Angiogr. Interv. 2, 100570 (2022). 10.1016/j.jscai.2022.100570 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
See the supplementary material for representative images of the Alizarin Red S stained carotid endarterectomy samples of the donors, representative bright-field images of the monolayer experiment, MTT assay data, and histological images and quantification of cellular proximity to HA particles.
Data Availability Statement
The data that support the findings of this study are available from the corresponding authors upon reasonable request.